Cambridge Trust’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$33.1K Buy
2,773
+13
+0.5% +$157 ﹤0.01% 471
2023
Q4
$29.9K Buy
2,760
+20
+0.7% +$192 ﹤0.01% 466
2023
Q3
$27K Sell
2,740
-23
-0.8% -$239 ﹤0.01% 471
2023
Q2
$27.6K Sell
2,763
-314
-10% -$3K ﹤0.01% 484
2023
Q1
$29.6K Hold
3,077
﹤0.01% 495
2022
Q4
$35K Sell
3,077
-943
-23% -$9.85K ﹤0.01% 489
2022
Q3
$35K Sell
4,020
-770
-16% -$7.58K ﹤0.01% 495
2022
Q2
$50K Sell
4,790
-441
-8% -$4.83K ﹤0.01% 484
2022
Q1
$57K Sell
5,231
-311
-6% -$4.1K ﹤0.01% 515
2021
Q4
$75K Buy
+5,542
New +$74K ﹤0.01% 469
2021
Q1
Sell
-10,133
Closed -$190K 275
2020
Q4
$190K Buy
+10,133
New +$165K 0.01% 227

Other funds holding VTRS

Cambridge Trust's VTRS Position: Q1 2024 in Review

Cambridge Trust increased its Viatris (VTRS) stake by 0.47% in Q1 2024, buying an estimated $157 and bringing the position to 2,773 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #471.

Cambridge Trust first reported a position in VTRS in Q4 2020 and has held it in 11 quarters since. The position peaked at $190K in Q4 2020. 1,008 funds tracked by Wall St. Rank hold VTRS as of Q1 2024.

  • Cambridge Trust held 2,773 shares of Viatris worth $33.1K as of Q1 2024.
  • Cambridge Trust bought 13 Viatris shares in Q1 2024, an estimated $157.
  • Viatris made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #471 holding.
  • Cambridge Trust first reported a position in Viatris in Q4 2020 and has held it in 11 quarters since.
  • Cambridge Trust's Viatris position peaked at $190K in Q4 2020.
  • 1,008 funds tracked by Wall St. Rank held Viatris as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.